KKPCF — Stock activity · TradeandTellKKPC
KKPCF
$26.00-$2.12 (-7.54%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$23.65 – $28.12
53% from low
Held by traders on TradeandTell
No one on the platform currently holds KKPCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in KKPCF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1461.54% ($380.00/share)
| Ex-date | Per share | Pay date |
|---|
| 2027-03-31 | $95.0000 | |
| 2026-09-30 | $95.0000 | |
| 2026-03-31 | $95.0000 | 2026-06-29 |
| 2025-09-30 | $95.0000 | 2025-11-28 |
| 2025-03-31 | $75.0000 | 2025-06-30 |
| 2024-09-30 | $75.0000 | 2024-11-29 |
| 2024-09-30 | $40.0000 | 2024-11-29 |
| 2024-03-28 | $75.0000 | 2024-06-28 |
| 2023-09-29 | $75.0000 | 2023-11-30 |
Recent trades on TradeandTell
No one on the platform has traded KKPCF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2027 | $84.7B | +2.4% | $124.07 | $108.86–$143.17 | 0.2× | 1 |
| 2028 | $83.5B | -1.5% | $95.93 | $84.17–$110.70 | 0.3× | 1 |
| 2029 | $84.1B | +0.8% | $92.62 | $81.26–$106.88 | 0.3× | 1 |
| 2030 | $76.6B | -8.9% | $80.43 | $70.57–$92.81 | 0.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-05-13 | $0.13 | $0.12 | -1.4% |
| 2026-02-06 | $0.16 | $0.07 | -56.8% |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| KKPCFKaken Pharmaceutical Co., Ltd. | $26.00 | +0.00% | $985M | — |
| AMPHAmphastar Pharmaceuticals, Inc. | $21.04 | +4.24% | $928M | — |
| AQSTAquestive Therapeutics, Inc. | $4.17 | -2.00% | $523M | — |
| BIOGYBioGaia AB (publ) | $12.36 | +0.00% | $1.3B | — |
| BIOVFSwedish Orphan Biovitrum AB (publ) | $48.20 |
| GNMLFGenomma Lab Internacional, S.A.B. de C.V. | $0.83 | +0.00% | $816M | — |
| HKMPFHikma Pharmaceuticals PLC | $22.28 | +0.00% | $4.7B | — |
Source: Financial Modeling Prep · peers by sector/industry